跳至主要内容
临床试验/NCT07749287
NCT07749287已完成3 期

Assessment of Therapeutic Role of H2S Donor in Acute Myocardial Infarction and Acute Cerebral Ischemia: Comparison in Animal Models and Clinical Cases.

Helwan University1 个研究点 分布在 1 个国家目标入组 121 人开始时间: 2021年6月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
3 期
状态
已完成
入组人数
121
试验地点
1
主要终点
Detect the effect of oral administration of NAC in critically ill acute ischemic stroke patients on the functional outcome.

研究概览

简要总结

  1. Clarify novel systemic and local inflammatory mechanisms underlying the cross talk between brain and heart ischemic states,
  2. Investigate the new aspects of NAC beyond traditional therapy, in cerebral and myocardial ischemic conditions, both in animal models and clinical cases.

详细描述

The study was conducted on 121 adult acute ischemic stroke patients admitted to stroke unit; either intermediate care or intensive care, of Kasr El Ainy Medical Hospital, Cairo University. Five patients were excluded as they didn't meet our eligibility criteria.

Oral form of NAC was given. Patients were divided into 4 groups:

  • Group I (AIS-IHD): critically ill AIS patients who had past history and / or current evidence of IHD (30 patients), Without administration of NAC (as a control group).
  • Group II (AIS-IHD-NAC): critically ill AIS patients who had past history and / or current evidence of ischemic heart disease (IHD) (30 patients), With nasogastric or oral administration of NAC.
  • Group III (AIS-NON-IHD): critically ill AIS patients who had Neither past history Nor current evidence of IHD (27 patients), Without administration of NAC (as a control group).
  • Group IV (AIS-NON-IHD-NAC): critically ill AIS patients who had Neither past history Nor current evidence of IHD (29 patients), With nasogastric or oral administration of NAC.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Outcomes Assessor)

盲法说明

Lab Technicians

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age above 18 years
  • AIS patients admitted into stroke unit
  • Onset within 48 hours
  • Glasgow coma scale (GCS) ≥ 8
  • Out of window or contraindicated for thrombolytics
  • Not arrested before

排除标准

  • Age below 18 years
  • Cerebral haemorrhage
  • Dural sinus thrombosis
  • Glasgow coma scale (GCS) < 8
  • Patients received thrombolytic
  • Post arrest

研究组 & 干预措施

Group I (AIS-IHD)

Placebo Comparator

critically ill AIS patients who had past history and / or current evidence of IHD (30 patients), With oral saline administration (as a control group).

干预措施: Normal (0.9%) saline (Drug)

Group II (AIS-IHD-NAC)

Active Comparator

critically ill AIS patients who had past history and / or current evidence of ischemic heart disease (IHD) (30 patients), With nasogastric or oral administration of NAC.

干预措施: N Acetyl cysteine 600mg (Drug)

Group III (AIS-NON-IHD)

Placebo Comparator

critically ill AIS patients who had Neither past history Nor current evidence of IHD (27 patients), With oral saline administration (as a control group).

干预措施: Normal (0.9%) saline (Drug)

Group IV (AIS-NON-IHD-NAC)

Active Comparator

critically ill AIS patients who had Neither past history Nor current evidence of IHD (29 patients), With nasogastric or oral administration of NAC.

干预措施: N Acetyl cysteine 600mg (Drug)

结局指标

主要结局

Detect the effect of oral administration of NAC in critically ill acute ischemic stroke patients on the functional outcome.

时间窗: At admission (on day 1), after 3 days (on day 4), and at discharge from hospital (up to day 30).

This outcome was assessed by evaluation of Glasgow Coma Score, the minimum and the worst = 3, and the maximum and the best = 15. It depends on assessment of Eye opening, Verbal response, Motor response. Also, evaluation of Modified Rankin Scale, for measuring the degree of disability following stroke, the maximum and the worst = 6, the minimum and the best = 0. Furthermore, evaluation of National Institutes of Health Stroke Scale (NIHSS), the most widely used functional assessment score for stroke, the maximum and the worst = 42, and the minimum and the best = 0. It depends on assessment of various clinical aspects, e.g., consciousness, orientation, vision, gaze, fascial palsy, speech, motor power, coordination, and sensation.

次要结局

  • Detect the effect of oral administration of NAC in critically ill acute ischemic stroke patients on the inflammatory storm and autophagy markers.(At admission (on day 1) and after 3 days (on day 4).)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mahmoud Mousad

Assistant Lecturer Master Degree

Helwan University

研究点 (1)

Loading locations...

相似试验